{"id":"W4388625669","doi":"10.25251/skin.7.supp.240","title":"Deucravacitinib in Plaque Psoriasis: 3-Year Safety and Efficacy Results From the Phase 3 POETYK PSO-1 and PSO-2 Trials","year":2023,"lang":"en","type":"article","venue":"SKIN The Journal of Cutaneous Medicine","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research; University of Toronto","funders":"National Institute for Health and Care Research; Manchester Biomedical Research Centre; Bristol-Myers Squibb","keywords":"Medicine; Psoriasis Area and Severity Index; Psoriasis; Placebo; Plaque psoriasis; Adverse effect; Apremilast; Internal medicine; Randomized controlled trial; Dosing; Dermatology; Psoriatic arthritis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004326124,0.0009914052,0.001601666,0.0003558703,0.0004918409,0.001417415,0.0006095027,0.001234493,0.002223755],"category_scores_gemma":[0.002437163,0.0003214595,0.002718796,0.0004252418,0.000447865,0.001141643,0.0003962723,0.002871,0.0005787676],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007655323,"about_ca_system_score_gemma":0.0009848764,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007936961,"about_ca_topic_score_gemma":0.002022217,"domain_scores_codex":[0.9986646,0.0005765114,0.0001004541,0.000206017,0.00025635,0.0001960363],"domain_scores_gemma":[0.9979016,0.0004424148,0.0007267261,0.000192476,0.0002706391,0.0004662095],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6111447,0.02089667,0.02467581,0.003575288,0.009907288,0.0003696008,0.00045535,0.005425299,0.02108533,0.0005079855,0.01799638,0.2839602],"study_design_scores_gemma":[0.5543901,0.2563043,0.1480611,0.0006613724,0.008983059,0.001650838,0.0002312514,0.004128677,0.00747743,0.001485947,0.01644901,0.0001769224],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9470094,0.03769911,0.001071793,0.001083827,0.0002094394,0.001807907,0.003753898,0.0001799552,0.00718461],"genre_scores_gemma":[0.9814236,0.009083324,0.000761701,0.001126424,0.0002791124,0.00101279,0.004801059,0.00003312318,0.001478893],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004326124,"threshold_uncertainty_score":0.022879,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03578117792347708,"score_gpt":0.304577256432096,"score_spread":0.2687960785086189,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}